William Patrick Scott, MD in Dardanelle, AR - General Practice

William Patrick Scott, MD is a General Practice physician based in Dardanelle, Arkansas. William Patrick Scott is licensed to practice in Arkansas (license number E-1903) and his current practice location is 200 N 3rd, Dardanelle, Arkansas. He can be reached at his office (for appointments etc.) via phone at (479) 229-6191.

NPI number for William Patrick Scott is 1881671055 and his current mailing address is Po Box 578, Dardanelle, Arkansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1881671055.

Contact Information

	William Patrick Scott, MD
	200 N 3rd, Dardanelle, AR 72834
	(479) 229-6191
	(479) 229-6194

Physician's Profile

Full Name	William Patrick Scott
Gender	Male
Speciality	General Practice
Location	200 N 3rd, Dardanelle, Arkansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1881671055
Provider Enumeration Date: 12/28/2005
Last Update Date: 12/08/2014

Medical Identifiers

Medical identifiers for William Patrick Scott such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1881671055	NPI	-	NPPES
136054001	Medicaid	AR

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	E-1903 (Arkansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. William Patrick Scott is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
William Patrick Scott, MD Po Box 578, Dardanelle, AR 72834-0578 Ph: (479) 229-6191	William Patrick Scott, MD 200 N 3rd, Dardanelle, AR 72834 Ph: (479) 229-6191

News Archive

Daiichi Sankyo files NDA for development and marketing of Methylene Blue medicinal product in Japan

Provepharm, a French company specialized in the development of pharmaceutical applications, today announces that Daiichi Sankyo, Co. Ltd., a global pharmaceutical firm, has filed an NDA (New Drug Application) for the development and marketing of the injectable Methylene Blue medicinal product in Japan, made out of Provepharm's Proveblue Methylene Blue active substance.

MFA reports that senior and Medicaid markets drive health enrollment gains

The nation's leading health insurers saw an aggregate increase of 363,000 members for the first six months of 2010. Declining commercial enrollment was offset primarily by gains in products offered to seniors and growth in Medicaid business. Administrative Services Only (ASO) enrollment gained 1.4 million members from December 2009 to June 2010. All of the leading health plans saw year-over-year profitability improvement.

Hygieia granted CE mark for d-Nav Diabetes Insulin Guidance System

Hygieia, Inc. today announced that the company's d-Nav Diabetes Insulin Guidance System (DIGS) has been granted a CE mark.

Comeback to a pre-injury level disappointing for professional baseball players

Only 45 percent of baseball players were able to return to the game at the same or higher level after shoulder or elbow surgery, according to new research released during the 2008 American Orthopaedic Society for Sports Medicine Specialty Day at The Moscone Center.

Surgeons describe positive outcomes in kidney cancer patients treated with robotic IVC thrombectomy

Surgery is required when cancer of the kidney causes a Level III thrombus, or clot, to develop in the major vein leading back to the heart. Traditionally this complicated procedure, inferior vena cava (IVC) thrombectomy, is performed using a large open incision, primarily because the vein is often difficult to reach.

William Patrick Scott, MD - General Practice in Dardanelle, AR